Halozyme Therapeutics (HALO) PT Raised to $48 at JMP Securities
Tweet
Share
E-mailGet Alerts HALO Hot Sheet
Price: $113.90 -1.15%
Rating Summary:
15 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
15 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
JMP Securities analyst Jason Butler raised the price target on Halozyme Therapeutics (NASDAQ: HALO) to $48.00 (from $45.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,030 at Citi
- Costco Wholesale (COST) PT Lowered to $1,010 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
